1. Study details.

Study ID	First author, year of publication
Patient sampling	Prospective/retrospective, case‐control/consecutive/random patient series
Patient characteristics and setting	Inclusion and exclusion criteria, previous tests for lung cancer (diagnosis and staging), clinical setting, sample size, age, sex, comorbidities, country, histology of primary tumour
Index test	Details of the index test used including the type of PET‐CT scanner, FDG dose, injection‐to‐scan time, attenuation correction, and the cut‐off values for test positivity (malignancy)
Reference standard(s)	The reference standard(s) used
Flow and timing	All participants were accounted for in results, missing/uninterpretable test results, reasons for withdrawal, adverse events caused by test, the time interval, and any interventions between index test(s) and reference standard
Notes	Source of funding, anything else of relevance

FDG = (¹⁸F)‐2‐fluoro‐deoxy‐D‐glucose.
 PET‐CT = positron emission tomography and computed tomography.